SENTINEL NODE BIOPSY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Sentinel Node Biopsy Market Size and Trends

The global sentinel node biopsy market is estimated to be valued at USD 752.1 Mn in 2024 and is expected to reach USD 1,209.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.

To learn more about this report, Request sample copy

The market is expected to witness lucrative growth over the forecast period owing to rising awareness about minimally invasive cancer staging techniques among patients and doctors. Technological advancements in imaging solutions to detect sentinel lymph nodes accurately is another key factor augmenting the demand for sentinel node biopsy. Adoption of robot-assisted sentinel lymph node biopsy systems will further support revenue generation in the coming years.

To learn more about this report, Request sample copy

Top Strategies Followed by the Global Sentinel Node Biopsy Market Players

• Established Players: Leading companies in the global sentinel node biopsy market focus heavily on research and development to drive innovation. They invest sizable portions of their revenue into developing new procedures, medical devices, imaging technologies, and biomarkers that can improve accuracy and outcomes for sentinel node biopsy.
• Mid-Level Players: Companies like Biomérieux are focusing on providing affordable diagnostic solutions. For example, in July 2022, Biomérieux launched a more cost-effective, point-of-care diagnostic test for sentinel lymph node biopsy aimed at hospitals in developing countries. This approach targets underserved markets with cost-sensitive patient populations, which has helped increase access to essential diagnostic services.
• Small-Scale Players: Smaller players such as OncoSyn focus on niche markets, developing highly specific sentinel node biopsy kits for specialized cancer types, like prostate and lung cancer. Their innovative product line, launched in June 2023, addresses the needs of patients in underserved regions where large-scale equipment is less accessible.

Emerging Startups in the Global Sentinel Node Biopsy Market

Innovative Technologies: Startups like LymphoTech, founded in 2021, are pioneering the use of smart sensors to enhance the precision of sentinel node biopsy procedures. LymphoTech's NIRF imaging technology, approved for clinical trials in July 2023, improves sentinel lymph node detection and reduces false-negative rates.

Sustainable Solutions: Startups focusing on sustainability are also emerging in the market. EcoBio Solutions, a company founded in 2022, specializes in biodegradable sentinel node biopsy agents. Their innovative material reduces environmental impact, as traditional biopsy dyes often contribute to chemical waste.

Market Contribution: Microscan Biotech, established in 2021, focuses on providing sentinel node biopsy solutions for rare cancers such as melanoma and non-small cell lung cancer (NSCLC). By developing specialized products that cater to specific oncological needs, Microscan is able to carve out a significant market share in a highly competitive space.